Article ID Journal Published Year Pages File Type
6190495 Cancer Treatment Reviews 2014 9 Pages PDF
Abstract
The use of anti-EGFR mAbs is associated with a significantly higher risk of high-grade infection and febrile neutropenia.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , ,